Raja Atreya - Concepedia

Author

Raja Atreya

Friedrich-Alexander-Universität Erlangen-Nürnberg ORCID

Also Known As

Armando Peixoto, Atreya, Raja, Aurelien Amiot, Geert R D’Haens, R ATREYA, R Atreya, R. ATREYA, R. Atreya, Raja Atreya, Raja N. Atreya

647

Publications

16.7K

Citations

H-Index

106

Concepts

All Affiliations

Friedrich-Alexander-Universität Erlangen-Nürnberg Universitätsklinikum Erlangen Bayreuth Medical Center Johannes Gutenberg University Mainz Charité - Universitätsmedizin Berlin

About

Raja Atreya is an author at Friedrich-Alexander-Universität Erlangen-Nürnberg specializing in medicine, gastroenterology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	45	4.6K
2	Health Sciences	6	6	214
3	Allergy	6	6	1.7K
4	Engineering	3	3	480
5	Public Health	1	1	37

Raja Atreya

139

Publications

12.1K

Citations

H-Index

Page 1

	Year	Citations
Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivo Raja Atreya, Jonas Mudter, Susetta Finotto, Nature Medicine InflammationChronic Inflammatory DiseasesCytokineAllergyMucosal Immunology	2000	1.3K
CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes Imke Tiede, Gerhard Fritz, Susanne Strand, Journal of Clinical Investigation	2003	801
Soluble gp130 is the natural inhibitor of soluble interleukin‐6 receptor transsignaling responses Thomas Jostock, Jürgen Müllberg, Suat Özbek, European Journal of Biochemistry	2001	640
Mongersen, an Oral <i>SMAD7</i> Antisense Oligonucleotide, and Crohn’s Disease Giovanni Monteleone, Markus F. Neurath, Sandro Ardizzone, New England Journal of Medicine	2015	391
TH9 cells that express the transcription factor PU.1 drive T cell–mediated colitis via IL-9 receptor signaling in intestinal epithelial cells Katharina Gerlach, Youyi Hwang, Alexej Nikolaev, Nature Immunology InflammationIl-9 ReceptorAllergyTh9 CellsMucosal Immunology	2014	390
In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease Raja Atreya, Helmut Neumann, Clemens Neufert, Nature Medicine InflammationEngineeringAutoimmune DiseaseImmunologyBiomedical Imaging	2014	378
Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection Miguel Regueiro, Brian G. Feagan, Bin Zou, Gastroenterology	2016	320
Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease Rebecca H. Haberman, Ramin S. Herati, David Simón, Annals of the Rheumatic Diseases	2021	264
Exacerbation of ulcerative colitis after rituximab salvage therapy Martin Goetz, Raja Atreya, M. Ghalibafian, Inflammatory Bowel Diseases	2007	261
Antibodies Against Tumor Necrosis Factor (TNF) Induce T-Cell Apoptosis in Patients With Inflammatory Bowel Diseases via TNF Receptor 2 and Intestinal CD14+ Macrophages Raja Atreya, Michael Zimmer, Brigitte Bartsch, Gastroenterology InflammationInduce T-cell ApoptosisCytokineTnf Receptor 2Autoimmune Disease	2011	247

Page 1